Video Monitoring Services Report [CC]=Derived from Closed Captioning; I=Interview; GR=Graphic; PC=Press Conference; R=Reader; SI=Studio Interview; T=Teaser; TZ=Teased Segment; V=Visual Client: Dune Margin Probe Television Coverage 02/24 through 02/26. Originating Station WCBS News at 5:00 PM WCBS-TV CH 2 (CBS) New York 02/24/2009 04:00 PM - 05:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:25:20 TZ; Tumor: The new MarginProbe tool could help breast cancer patients choose between mastectomy and lumpectomy. I; Patient talked about lumpectomies. V; Surgery scenes. I; Dr. Susan Boolbol, Beth Israel Medical Center, talked about the tool’s uses. V; Dune Margin Probe, which tests tumors in the operating room. 00:26:50. Affiliated Stations 1. KCAL 9 News At 4:00 PM DMA: 2 KCAL-TV CH 9 (IND) Los Angeles 02/25/2009 04:00 PM - 05:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:40:26 TZ; New Tool: A new tool allows doctors to remove all the cancerous breast tissue during a single lumpectomy. V; surgery. I; Dr. Susan Boolbol of Beth Israel Medical Center says half of the women who have lumpectomies usually have to have another operation to remove more. 00:41:22 . 2. KCAL 9 News At 2:00 PM DMA: 2 KCAL-TV CH 9 (IND) Los Angeles 02/25/2009 02:00 PM - 03:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:57:17 TZ; Health: Breast cancer treatment featured. I; Patient talked about treatment. I; Dr. Susan Boolbol, Beth Israel Med Ctr, talked about lumpectomy reincision rates. V; Dune Margin Probe, tests tumor in operating room. Karen Brown reporting. 00:59:11 . 3. KCAL 9 News At 12:00 Noon DMA: 2 KCAL-TV CH 9 (IND) Los Angeles 02/25/2009 12:00 PM - 01:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:46:16 TZ; Cancer: A new device has been developed to treat women with breast cancer. The device lessens the chance that a lumpectomy will have to be repeated. I; Cheryl Victor, breast cancer patient, says she opted for a lumpectomy. I; Susan Boolbol, Dr, Beth Israel Medical Center, says lumpectomy surgeries often have to be repeated later. The first clinical trial was done in Israel, and it hasn’t yet been approved in the US. V; Medical scenes. Karen Brown reporting. 00:48:09 . 4. CBS 2 News At 5:00 PM DMA: 3 WBBM-TV CH 2 (CBS) Chicago 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:17:13 TZ; Breast Cancer: A new tool could eliminate repeat breast cancer surgeries. V; Video of a surgery using the probe. I; Dr. Susan Boolbol, Beth Israel Medical Center, talks about how the tool allows doctors to remove extra cancer cells. The probe could approved by the FDA by 2010. 00:17:54 . 5. CBS 11 News At Five DMA: 5 KTVT-TV CH 11 (CBS) Dallas/Fort Worth 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:25:20 TZ; Tumor: A new tool could help breast cancer patients choose between mastectomy and lumpectomy. I; Patient talked about lumpectomies. V; Surgery scenes. I; Dr. Susan Boolbol, Beth Israel Medical Center, talked about the tool’s uses. V; Dune Margin Probe, which tests tumors in the operating room. 00:26:50 . 6. CBS 5 Eyewitness News At 6 PM DMA: 6 KPIX-TV CH 5 (CBS) San Francisco 02/25/2009 06:00 PM - 07:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:26:20 Breast Cancer: A new device has been developed to treat women with breast cancer. The device lessens the chance that a lumpectomy will have to be repeated. I; Cheryl Victor, breast cancer patient, says she opted for a lumpectomy. V; Medical scenes. I; Susan Boolbol, Dr, Beth Israel Medical Center, says lumpectomy surgeries often have to be repeated later. The first clinical trial was done in Israel, and it hasn’t yet been approved in the US. Dr Kim Mulvihill reporting. 00:29:20 . 7. CBS 46 News At 4:00 DMA: 8 WGCL-TV CH 46 (CBS) Atlanta 02/25/2009 04:00 PM - 05:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:51:29 TZ; Breast: A new tool could help breast cancer patients choose between mastectomy and lumpectomy. V; Surgery scenes. V; Dune Margin Probe, which tests tumors in the operating room. I; Dr. Boolbol, Beth Israel Medical Center, talked about the tool’s uses. 00:52:10 . 8. 9 News Now Tonight DMA: 9 WUSA-TV CH 9 (CBS) Washington, DC 02/25/2009 07:00 PM - 07:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:16:01 Living Well: There is a new tool that doctors are using to treat women with Brest Cancer. I; Cheryl Victor, Breast Cancer Patient, talks about her lumpectomy that she had done. I Dr. Susan K Boolbol, Beth Israel Medical Center, talks about the reinsertion rate, says that if this tool can determine if there are cancer cells then we can remove more of the tissue then. V; The Dune Margin Probe. The Maker of the Dune Margin Probe says that the data was collected and sent to the FDA and could be approved by 2010. 00:18:06 . 9. CBS 5 News At 5 DMA: 12 KPHO-TV CH 5 (CBS) Phoenix 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:26:29 Breast Cancer: Breast cancer patients have the option of mastectomy of lumpectomy, but a new tool called the Dunn Margin Probe tests tumors while the patient is still in the OR. V; Tool being used in surgery. I; Dr. Susan Boobol, Beth Israel Med. Center, said if this tool can consistently tell us if there are cancer sells, they can remove extra tissue then. The tool is being tested at 11 hospitals and does not have Food and Drug Administration approval. 00:27:04 . 10. Local 6 News @ 5:30 DMA: 19 WKMG-TV CH 6 (CBS) Orlando 02/25/2009 05:30 PM - 06:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:14:06 TZ; Cancer Surgery: A new tool will allow doctors to better remove cancerous breast tissue. I; patient says she chose to have a lumpectomy. V; surgery. I; Dr. Susan K. Boolbol of Beth Israel Medical Center says nearly half of women return to the operating room after a lumpectomy. V; margin probe. Karen Brown reporting. 00:16:03 . 11. Eyewitness News At 5:00 PM DMA: 30 WFSB-TV CH 3 (CBS) Hartford/New Haven 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard 00:28:54 Breast Cancer: Mastectomy and Lumpectomy treatments with breast cancer are talked about as a new tool in the fight is discussed. I; Cheryl Victor talking about getting her lumpectomy. I; Dr. Susan K. Boolbol, Beth Israel Medical Center, talking about treating cancer with lumpectomy and talks about a new tool. V; Breast Cancer surgery. Karen Brown reporting. 00:30:51 . 12. 10:00 PM News DMA: 34 WKRC-DT2 CH 31 (CW) Cincinnati 02/25/2009 10:00 PM - 10:30 PM [CC] 00:16:50 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:19:50 . 13. News 2 At 5:00 DMA: 46 WFMY-TV CH 2 (CBS) Greensboro/Winston-Salem 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:25:59 But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:28:59 . 14. NewsChannel 3 At 4:30 PM DMA: 48 WREG-TV CH 3 (CBS) Memphis 02/25/2009 04:30 PM - 05:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:16:04 Breast cancer patients facing a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:19:04 . 15. NewsChannel 32 5:00 Report DMA: 50 WLKY-TV CH 32 (CBS) Louisville 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:26:04 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:29:04 . 16. WKRG 5 News At 5 DMA: 60 WKRG-TV CH 5 (CBS) Mobile/Pensacola 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:24:24 Breast cancer patients facing a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:27:24 . 17. NewsCenter 7 At 5:30 DMA: 64 WHIO-TV CH 7 (CBS) Dayton 02/25/2009 05:30 PM - 06:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:24:54 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:27:54 . 18. WNEM-5 News At 5:30 DMA: 66 WNEM-TV CH 5 (CBS) Flint/Saginaw/Bay City 02/25/2009 05:30 PM - 06:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:30:50 Breast cancer patients facing a daunting choice ---mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:33:50 . 19. News Channel 8 This Morning DMA: 71 KCCI-TV CH 8 (CBS) Des Moines/Ames 02/26/2009 05:00 AM - 06:00 AM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:24:52 When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin -- the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:27:52 . 20. News Channel 8 At Ten DMA: 71 KCCI-TV CH 8 (CBS) Des Moines/Ames 02/25/2009 10:00 PM - 10:35 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:25:09 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:28:09 . 21. KGMB9 News At Five DMA: 72 KGMB-TV CH 9 (CBS) Honolulu 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:23:13 Breast cancer patients facing a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:26:13 . 22. News 22 DMA: 89 WSBT-TV CH 22 (CBS) South Bend/Elkhart 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:23:46 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:26:46 . 23. 11 News At 4:00 DMA: 91 KKTV-TV CH 11 (CBS) Colorado Springs/Pueblo 02/25/2009 04:00 PM - 04:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:23:56 Breast cancer patients facing a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:26:56 . 24. NewsChannel 11 At 5:00 DMA: 92 WJHL-TV CH 11 (CBS) Tri-Cities 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:23:02 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:26:02 . 25. Channel 3 News At 6 DMA: 93 WCAX-TV CH 3 (CBS) Burlington/Plattsburgh 02/25/2009 06:00 PM - 07:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:35:50 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:38:50 . 26. News 10 This Morning DMA: 94 KWTX-TV CH 10 (CBS) Waco/Temple 02/26/2009 05:30 AM - 06:00 AM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:15:50 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:18:50 . 27. News 10 At 5 DMA: 94 KWTX-TV CH 10 (CBS) Waco/Temple 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:20:50 Breast Cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:23:50 . 28. 10-11 This Morning DMA: 106 KOLN-TV CH 10 (CBS) Lincoln/Hastings/Kearney 02/26/2009 06:00 AM - 07:00 AM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:24:18 Breast cancer patients are facing a daunting choice: Mastectomy or lumpectomy. For many, it’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. CBS’ Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. Cheryl Victor, breast cancer patient 00:04-00:10dr. Susan K. Boolbol, Chief of Breast Surgery, Beth Israel Medical Center 00:24-00:33Karen Brown, CBS News, NYC 00:51-01:04trt: 1:35(Pkg script) Nat Sot-”How are you feeling? Fine.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot- Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re- excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:27:18 . 29. CBS 3 Springfield News At 6:00 DMA: 111 WSHM-TV CH 3 (CBS) Springfield/Holyoke, MA 02/25/2009 06:00 PM - 06:30 PM [CC] 00:24:19 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:27:19 . 30. CBS 2 Eyewitness News At 4 DMA: 112 KBCI-TV CH 2 (CBS) Boise 02/25/2009 04:00 PM - 04:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:15:15 When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin -- the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:18:15 . 31. News 12 DMA: 115 WRDW-TV CH 12 (CBS) Augusta 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:25:23 Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:28:23 . 32. 12 News At 5 DMA: 121 KCOY-TV CH 12 (CBS) Santa Barbara/Santa Maria/San Luis Obispo 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:27:27 Breast cancer patients facing a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:30:27 . 33. NewsChannel 8 This Morning DMA: 127 WKBT-TV CH 8 (CBS) La Crosse/Eau Claire 02/26/2009 05:30 AM - 06:00 AM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:19:40 When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin -- the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:22:40 . 34. News 7 At 5 DMA: 135 WSAW-TV CH 7 (CBS) Wausau/Rhinelander 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:19:15 Cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:22:15 . 35. KRCG News Nightside DMA: 137 KRCG-TV CH 13 (CBS) Columbia/Jefferson City 02/25/2009 10:00 PM - 10:35 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:24:47 Many breast cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Anyone with cancer wants to beat it with as little pain as possible. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot- Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re- excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:27:47 . 36. Live At Five DMA: 138 WIBW-TV CH 13 (CBS) Topeka 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:19:20 Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:22:20 . 37. Live At Five DMA: 141 KFDM-TV CH 6 (CBS) Beaumont/Port Arthur 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:11:40 Cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:14:40 . 38. KOAM Morning News DMA: 148 KOAM-TV CH 7 (CBS) Joplin/Pittsburg 02/26/2009 05:30 AM - 06:00 AM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:27:20 When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin -- the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:30:20 . 39. KOAM News At Five DMA: 148 KOAM-TV CH 7 (CBS) Joplin/Pittsburg 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:12:48 Breast Cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:15:48 . 40. KMEG News Sunrise DMA: 149 KMEG-TV CH 14 (CBS) Sioux City 02/26/2009 05:00 AM - 06:00 AM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:46:04 When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin -- the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:49:04 . 41. KMEG News Nightcast DMA: 149 KMEG-TV CH 14 (CBS) Sioux City 02/25/2009 10:00 PM - 10:35 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:23:13 Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot- Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re- excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:26:13 . 42. News 10 This Morning DMA: 152 WTHI-TV CH 10 (CBS) Terre Haute 02/26/2009 06:00 AM - 07:00 AM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:47:05 When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin -- the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:48:04 . 43. News Channel 3 At 5PM DMA: 154 KIMT-TV CH 3 (CBS) Rochester/Mason City/Austin 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, transcript [CC] 00:25:09 Breast Cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:28:09 . 44. 59 News At 5 DMA: 155 WVNS-TV CH 59 (CBS) Bluefield/Beckley/Oak Hill 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:24:09 When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:27:09 . 45. Eye On Dakota 5 O’Clock News DMA: 158 KXMC-TV CH 13 (CBS) Minot/Bismark 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, transcript [CC] 00:18:37 Breast Cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:21:37 . 46. Channel 3 Eyewitness News DMA: 162 KIDK-TV CH 3 (CBS) Idaho Falls 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, transcript [CC] 00:24:49 Cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:27:49 . 47. KPAX News At 10 DMA: 166 KPAX-TV CH 8 (CBS) Missoula 02/25/2009 10:00 PM - 10:35 PM Available formats: QuickView, transcript [CC] 00:25:19 Breast cancer daunting choice --mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Now, there is a new tool used in surgery for breast cancer patients that is less invasive, and could help doctors get all of the cancer the first time. When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:28:19 . 48. CBS19 News At Five DMA: 183 WCAV-TV CH 19 (CBS) Charlottesville 02/25/2009 05:00 PM - 06:00 PM [CC] 00:33:08 In tonight’s Health Watch--Cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00: 36:08 . 49. News Source 8 First Edition DMA: 204 WAGM-TV CH 8 (CBS) Presque Isle 02/25/2009 05:30 PM - 06:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:23:01 Karen Brown shows us a new tool that could help doctors get all of the cancer the first me. Pkg script) (nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot- Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re- excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:26:01 . 50. Channel 11 News At 11 DMA: 208 WBKB-TV CH 11 (CBS) Alpena 02/25/2009 11:00 PM - 11:35 PM Available formats: QuickView, transcript [CC] 00:12:02 When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin -- the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. ( Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” (Bridge, Karen Brown CBS News NYC) “The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. 00:15:02 51. Ohio This Morning DMA: 17 Ohio News Network (---) Cleveland/Akron 02/26/2009 06:00 AM - 07:00 AM 00:15:06 TZ; Breast cancer surgery tool: A new breast cancer surgery tool face a hard choice about whether or not to have a more invasion surgery. I; Cheryl Victor, Breast cancer patient, Comments on preferring a lumpectomy. V; Surgery being performed. I; Dr. Susan Boolbol, Beth Israel Medical Center, Comments on the number of woman who often have to have subsequent surgeries and talks about the potential benefits of the new tool. The Dune Margin Probe tests the tumor in the operating room. Karen Brown of CBS News reports. 00:17:08 .. 52. News 12 At Noon DMA: 86 WDEF-TV CH 12 (CBS) Chattanooga/Cohutta 02/26/2009 12:00 PM - 12:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:20:45 Breast cancer patients face a daunting choice: mastectomy or lumpectomy. While the lumpectomy is less invasive, surgeons often end up operating more than once. But in tonight’s Health Watch, a new tool that could help doctors get all of the cancer the first time. “How are you feeling? Fine.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But, with a lumpectomy comes e risk of more surgery. When a tumor is removed it is sent to a pathologist and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. (Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But, a new tool may help surgeons get the job done the first time around. The dune margin probe tests the tumor in the operating room, while the patient is still on the table. (Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. Dr. Boolbol used the margin probe on handheld device. 00:23:45 . 53. The News At 5 PM DMA: 96 WTOC-TV CH 11 (CBS) Savannah 02/26/2009 05:00 PM - 06:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:27:19 Breast cancer patients face a daunting choice: mastectomy or lumpectomy. While the lumpectomy is less invasive, surgeons often end up operating more than once. But in tonight’s Health Watch, a new tool that could help doctors get all of the cancer the first time. “How are you feeling? Fine.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But, with a lumpectomy comes e risk of more surgery. When a tumor is removed it is sent to a pathologist and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. (Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But, a new tool may help surgeons get the job done the first time around. The dune margin probe tests the tumor in the operating room, while the patient is still on the table. (Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. Dr. Boolbol used the margin probe on handheld device. 00:30:19 . 54. Channel 2 News 5:30 PM DMA: 108 KTVN-TV CH 2 (CBS) Reno 02/26/2009 05:30 PM - 06:00 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:21:06 Breast cancer patients face a daunting choice: mastectomy or lumpectomy. While the lumpectomy is less invasive, surgeons often end up operating more than once. But in tonight’s Health Watch, a new tool that could help doctors get all of the cancer the first time. “How are you feeling? Fine.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But, with a lumpectomy comes e risk of more surgery. When a tumor is removed it is sent to a pathologist and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. (Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But, a new tool may help surgeons get the job done the first time around. 00:24:06 . 55. 9/10 News At Noon DMA: 117 WWTV-TV CH 9 (CBS) Traverse City/Cadillac 02/26/2009 12:00 PM - 12:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:27:35 Breast cancer patients face a daunting choice: mastectomy or lumpectomy. While the lumpectomy is less invasive, surgeons often end up operating more than once. But in tonight’s Health Watch, a new tool that could help doctors get all of the cancer the first time. “How are you feeling? Fine.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But, with a lumpectomy comes e risk of more surgery. When a tumor is removed it is sent to a pathologist and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. (Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But, a new tool may help surgeons get the job done the first time around. The dune margin probe tests the tumor in the operating room, while the patient is still on the table. (Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. Dr. Boolbol used the margin probe on handheld device. 00:30:35 . 56. NewsChannel 8 At Noon DMA: 127 WKBT-TV CH 8 (CBS) La Crosse/Eau Claire 02/26/2009 12:00 PM - 12:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:21:49 Breast cancer patients face a daunting choice: mastectomy or lumpectomy. While the lumpectomy is less invasive, surgeons often end up operating more than once. But in tonight’s Health Watch, a new tool that could help doctors get all of the cancer the first time. “How are you feeling? Fine.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But, with a lumpectomy comes e risk of more surgery. When a tumor is removed it is sent to a pathologist and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. (Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But, a new tool may help surgeons get the job done the first time around. The dune margin probe tests the tumor in the operating room, while the patient is still on the table. (Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. Dr. Boolbol used the margin probe on handheld device. 00:24:49 .. 57. First News At Noon DMA: 161 KXII-TV CH 12 (CBS) Sherman/Dennison 02/26/2009 12:00 PM - 12:30 PM Available formats: QuickView, transcript [CC] 00:14:07 Breast cancer patients face a daunting choice: mastectomy or lumpectomy. While the lumpectomy is less invasive, surgeons often end up operating more than once. But in tonight’s Health Watch, a new tool that could help doctors get all of the cancer the first time. “How are you feeling? Fine.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But, with a lumpectomy comes e risk of more surgery. When a tumor is removed it is sent to a pathologist and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. (Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But, a new tool may help surgeons get the job done the first time around. The dune margin probe tests the tumor in the operating room, while the patient is still on the table. (Sot-Dr. Boolbol): “If this tool can consistently tell us, are there cancer cells we can actually remove extra tissue then.” The first clinical trial in Israel showed the probe reduced repeat surgeries by 56 percent. Not yet approved here in the United States, it is now being tested on 700 patients at 14 hospitals across the country. Dr. Boolbol used the margin probe on handheld device. 00:17:07 58. News Channel 8 At Ten DMA: 71 KCCI-TV CH 8 (CBS) Des Moines/Ames 02/25/2009 10:00 PM - 10:35 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:24:52 When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin -- the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. 00:27:52 59. 59 News At 5 DMA: 155 WVNS-TV CH 59 (CBS) Bluefield/Beckley/Oak Hill 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:24:09 When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. ( Sot-Dr. Susan Boolbol, Beth Israel Medical Center): “The re-excision rate varies from about 20 percent to 50 percent. So in some hands, half of every woman that they are operating on needs to go back to the operating room.” But a new tool may help surgeons get the job done the first time around. The Dune Margin Probe tests the tumor in the operating room, while the patient is still on the table. 00:27:09 60. Channel 3 Eyewitness News DMA: 162 KIDK-TV CH 3 (CBS) Idaho Falls 02/25/2009 05:00 PM - 05:30 PM Available formats: QuickView, DVD, CD, digital link, videotape, transcript, NewsBoard [CC] 00:24:49 Cancer patients face a daunting choice: mastectomy or lumpectomy. It’s a difficult decision. While the lumpectomy is less invasive, surgeons often end up operating more than once. Karen Brown shows us a new tool that could help doctors get all of the cancer the first time. (Nat sot) “Post op recovery was good? Perfect.” When Cheryl Victor was diagnosed with breast cancer, she chose to have a lumpectomy. ( Sot-Cheryl Victor, breast cancer patient): “Of course I was grateful, because a lumpectomy you still have your breast!” But with a lumpectomy comes the risk of more surgery. When a tumor is removed it is sent to a pathology lab and if cancer is found at or near the edge --or the margin --the patient must undergo more surgery. 00:27:49 |
